Literature DB >> 7126622

Ether phospholipids in guinea pig polymorphonuclear leukocytes and macrophages. Occurrence of high levels of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine.

T Sugiura, Y Onuma, N Sekiguchi, K Waku.   

Abstract

Significant proportions of the choline phosphoglycerides (CPG) were found to contain alkyl either-type moieties (e.g., 1-O-alkyl-2-acyl-glycero-3-phosphocholine) in both guinea pig peritoneal exudate polymorphonuclear leukocytes (16.4%) and macrophages (13.5%). High proportions of the ethanolamine phosphoglycerides (EPG) contained alkenyl either moieties in both cells (37.2 and 41.2%), while the proportions of the CPG containing alkenyl moieties and of the EPG containing alkyl moieties were shown to be small. The either phospholipid composition as well as the fatty chain profiles of these two types of cells had relatively similar patterns. However, the fatty chains at the 1- and 2-positions for alkenyl either, alkyl ether and diacyl phosphoglycerides showed considerable differences. The amount of 16:0 at the 1-position was higher in alkyl compounds than that in diacyl compounds of the CPG. This was also the case in either-containing and diacyl EPG. The most predominant fatty acids at the 2-position was 18:2, in each lipid class, except for the alkenyl CPG. The amounts of 20:4 and other polyunsaturated fatty acids were low in every lipid class, though ether compounds contained higher amounts of 20:4 than diacyl compounds, particularly for EPG.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7126622

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Effects of dietary n-3 and n-6 polyunsaturated fatty acids on macrophage phospholipid classes and subclasses.

Authors:  R S Chapkin; S L Carmichael
Journal:  Lipids       Date:  1990-12       Impact factor: 1.880

2.  Lysophospholipids from the Guangxi Sponge Spirastrella purpurea.

Authors:  Kun Lin; Peng Yang; Hui Yang; Ai-Hong Liu; Li-Gong Yao; Yue-Wei Guo; Shui-Chun Mao
Journal:  Lipids       Date:  2015-06-03       Impact factor: 1.880

3.  Platelet-activating factor modulates phospholipid acylation in human neutrophils.

Authors:  J S Tou
Journal:  Lipids       Date:  1987-05       Impact factor: 1.880

4.  Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether.

Authors:  R A Zoeller; A C Lake; N Nagan; D P Gaposchkin; M A Legner; W Lieberthal
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

5.  Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.

Authors:  T Y Shen; S B Hwang; M N Chang; T W Doebber; M H Lam; M S Wu; X Wang; G Q Han; R Z Li
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

6.  Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.

Authors:  A Dulioust; E Vivier; N Meslier; R Roubin; I Haye-Legrand; J Benveniste
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

7.  1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.

Authors:  H W Mueller; A D Purdon; J B Smith; R L Wykle
Journal:  Lipids       Date:  1983-11       Impact factor: 1.880

8.  Metabolism of platelet-activating factor by blood platelets and plasma.

Authors:  I Alam; J B Smith; M J Silver
Journal:  Lipids       Date:  1983-08       Impact factor: 1.880

9.  Incorporation of arachidonic acid and eicosapentaenoic acid into phospholipids by polymorphonuclear leukocytes in vitro.

Authors:  J S Tou
Journal:  Lipids       Date:  1984-08       Impact factor: 1.880

10.  Lipid changes in HL-60 cells on differentiation into macrophages by treatment with a phorbol ester.

Authors:  R Manning; A Fallani; S Ruggieri
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.